‘All Indians are proud that approved vaccines were made in India’: PM Modi after DCGI nod


After the The Comptroller General of Drugs of India (DCGI) approved on Sunday the emergency use of Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin for Covid-19 immunization in India, Prime Minister Narendra Modi tweeted that all Indians are proud that both injections are “made in India.”

Stating that the DGCI approval shows the “enthusiasm of our scientific community to fulfill the dream of an Aatmanirbhar Bharat”, Prime Minister Modi tweeted: “All Indians would be proud that the two vaccines that received approval from! emergency use are manufactured in India! This shows the enthusiasm of our scientific community to fulfill the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion. “

“We reiterate our gratitude to the doctors, medical personnel, scientists, police personnel, sanitation workers and all the warriors of Corona for the excellent work carried out, also in adverse circumstances. We will be eternally grateful to them for saving many lives, “added Prime Minister Modi.

Two vaccines for the coronavirus, Covishield from the Serum Institute and Covaxin from Bharat Biotech, received emergency approval from the country’s drug regulator today. India’s Comptroller General for Drugs VG Somani said both firms submitted data on their tests and both were granted permission for “restricted use.”

Shortly after DCGI’s nod, Adar Poonawalla, Executive Director of the Serum Institute of India (SII), tweeted: “Happy New Year everyone! All the risks that @SerumInstIndia took in storing the vaccine have finally paid off. COVISHIELD, India’s first COVID-19 vaccine is approved, safe, effective and ready to roll out in the next few weeks. “

“After proper review, CDSCO has decided to accept the Expert Committee’s recommendations and consequently the Serum Institute and Bharat Biotech vaccines are being approved for restricted use in emergency situations and permission is being granted to Cadila Healthcare for the conducting the Phase III clinical trial, ”said the DCGI. “We will never approve anything if there is the slightest security problem. Vaccines are 110% safe. Some side effects like mild fever, pain, and allergy are common to all vaccines. It (that people become powerless) is absolute nonsense, ”he said after the press, the ANI news agency reported.

While reviewing the trial at Delhi’s GTB hospital on Saturday, Health Minister Harsh Vardhan said that vaccines would be administered at no cost to priority groups in the first phase of the vaccination campaign in India. This includes one crore from healthcare workers and two crore from frontline workers. Vardhan said details of the second phase are being worked out in July, which will include vaccines for 27 million more beneficiaries.

.